Search
Pilot Pharmaceutical Biotechnology Experiences 239% Surge, Announces Intent to Acquire Conflux's Full Shareholding for Blockchain Entry
2 day ago /
Read about 0 minute
Author：小编
Shares of Pilot Pharmaceutical Biotechnology skyrocketed by an astonishing 239% at market open, reaching a seven-year peak before moderating gains to settle at 77%. The company has unveiled ambitious plans to acquire 100% of the target company, which in turn holds Conflux blockchain assets. This strategic acquisition underscores Pilot Pharmaceutical Biotechnology's commitment to expanding its footprint in the blockchain sector and fostering a diversified business landscape.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
